Sign In

Login

Password

Forgot Password ? Sign Up

Zastaprazan (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zastaprazan" in English language version.

refsWebsite
Global rank English rank
4nih.gov
4th place
4th place
3doi.org
2nd place
2nd place
1springer.com
274th place
309th place

doi.org (Global: 2nd place; English: 2nd place)

  • Yang E, Hwang I, Ji SC, Kim J, Lee S (December 2024). "Population pharmacokinetic analysis of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in patients and healthy volunteers". CPT: Pharmacometrics & Systems Pharmacology. 13 (12): 2150–2158. doi:10.1002/psp4.13228. PMC 11646930. PMID 39268835.
  • Tietto A, Faggin S, Scarpignato C, Savarino EV, Giron MC (September 2024). "Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease". Expert Opinion on Drug Metabolism & Toxicology. 21 (1): 53–68. doi:10.1080/17425255.2024.2397433. PMID 39189409.
  • Blair HA (July 2024). "Zastaprazan: First Approval". Drugs. 84 (7): 863–866. doi:10.1007/s40265-024-02057-w. PMID 38916840.

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

  • Yang E, Hwang I, Ji SC, Kim J, Lee S (December 2024). "Population pharmacokinetic analysis of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in patients and healthy volunteers". CPT: Pharmacometrics & Systems Pharmacology. 13 (12): 2150–2158. doi:10.1002/psp4.13228. PMC 11646930. PMID 39268835.
  • Tietto A, Faggin S, Scarpignato C, Savarino EV, Giron MC (September 2024). "Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease". Expert Opinion on Drug Metabolism & Toxicology. 21 (1): 53–68. doi:10.1080/17425255.2024.2397433. PMID 39189409.
  • Blair HA (July 2024). "Zastaprazan: First Approval". Drugs. 84 (7): 863–866. doi:10.1007/s40265-024-02057-w. PMID 38916840.

ncbi.nlm.nih.gov

  • Yang E, Hwang I, Ji SC, Kim J, Lee S (December 2024). "Population pharmacokinetic analysis of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in patients and healthy volunteers". CPT: Pharmacometrics & Systems Pharmacology. 13 (12): 2150–2158. doi:10.1002/psp4.13228. PMC 11646930. PMID 39268835.

springer.com (Global: 274th place; English: 309th place)

adisinsight.springer.com